Recent episodes have brought to top of mind the need for early virus detection. However, there are many viruses whose effects can be limited by early and/or pre-symptomatic detection. Join us for a talk with two leading Johnson & Johnson Innovation – JLABS companies to learn about their diagnostic approaches and views on protecting individuals in the current and any potential future crises.
Jeff Calcagno , MD – Head of JLABS Bay Area
Trevor Martin, Ph.D. – Co- Founder and CEO Mammoth Biosciences
David Seftel, MD – Co-Founder and CEO Enable Biosciences